FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.
Clinical trial NCT00270361 · COMPLETED
Trial details
- NCT number
- NCT00270361
- Sponsor
- Scios, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.